Anthera Pharmaceuticals

^{, Nasdaq: ANTH}

Developing anti-inflammatory therapies for acute coronary syndrome and lupus.

Industry: Health Care

First Day Return: +0.1%

ANTH

Developing anti-inflammatory therapies for acute coronary syndrome and lupus.

IPO News for Anthera Pharmaceuticals

Anthera Pharma quiet period ends April 9 04/04/10
Anthera Pharmaceuticals prices IPO at $7, 50 percent below the proposed range 03/01/10
1 IPO planned for the week of Mar 1 02/28/10

IPO Data
IPO Date	02/28/2010
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$42
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.anthera.com
Headquarters	Hayward, CA, United States
Founded	2004
Employees at IPO	n/a

IPO News for Anthera Pharmaceuticals

Anthera Pharma quiet period ends April 9 04/04/10
Anthera Pharmaceuticals prices IPO at $7, 50 percent below the proposed range 03/01/10
1 IPO planned for the week of Mar 1 02/28/10

Anthera Pharmaceuticals (ANTH) Performance